1. Home
  2. OBAI vs SNGX Comparison

OBAI vs SNGX Comparison

Compare OBAI & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

HOLD

Current Price

$0.23

Market Cap

9.4M

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.38

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBAI
SNGX
Founded
2017
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
8.2M
IPO Year
2025
2006

Fundamental Metrics

Financial Performance
Metric
OBAI
SNGX
Price
$0.23
$0.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
★ 558.8K
202.7K
Earning Date
05-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
40.53
★ 57.03
EPS
N/A
★ N/A
Revenue
★ $9,972,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 2.42
N/A
52 Week Low
$0.21
$0.28
52 Week High
$19.95
$1.97

Technical Indicators

Market Signals
Indicator
OBAI
SNGX
Relative Strength Index (RSI) 33.79 44.98
Support Level N/A $0.35
Resistance Level $0.65 $0.41
Average True Range (ATR) 0.03 0.01
MACD -0.00 0.00
Stochastic Oscillator 25.25 33.11

Price Performance

Historical Comparison
OBAI
SNGX

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: